Health

Results: 373-384 of 4413

Cencora to Host Inaugural Product Showcase

Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients

Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference

OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference

iTeos to Participate in Upcoming Investor Conferences

Delta-Fly Pharma Inc.: Progress Update of the Phase III Clinical Trial of DFP-14323

PR Newswire associated0

Great Ormond Street Hospital Delegation Participates in International Conjoined Twins Conference

PR Newswire associated0

Zentiva secures approx. 85.27% of APONTIS PHARMA AG voting rights in the context of its public purchase offer

PR Newswire associated0

Monument Therapeutics Launches First Clinical Study of MT1988, a Novel Treatment for Cognitive Impairment Associated with Schizophrenia

MPs to vote on landmark smoking ban to stop cycle of addiction

PR Newswire associated0

Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU® (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC)

Sudden Hearing Loss Study Reaches Milestone: AudioCure Pharma Enrolls More Than Half of the Patients in AC102 Study